Cilcare selected as a finalist for the 2025 EEN Awards

Cilcare is proud to announce its selection as one of the three finalists for the Enterprise Europe Network Award 2025, an annual recognition highlighting European SMEs that have successfully leveraged the Network’s support to accelerate their international development. 

Over the years, the EEN has played a pivotal role in supporting Cilcare’s international expansion by facilitating access to key ecosystems and partners across Europe and Asia. This includes participation in the EU-Japan Biotech Missions, designed to connect European SMEs with leading Japanese biotech players, as well as guidance throughout several stages of the EIC Accelerator applications. 

Being selected as a finalist for the 2025 EEN Awards is a recognition of the impact of this long-standing collaboration and the Network’s contribution to accelerating innovative projects on a global scale. 

“Being named a finalist for the EEN Awards reflects the value of the support we have received and the quality of the opportunities enabled by the Network. We are deeply thankful and eagerly look forward to the Awards ceremony on 28 November !”, says Célia Belline, CEO of Cilcare. 

The EEN Awards ceremony will take place on 28 November in Aalborg, Denmark, during the Network’s Annual Conference, honoring the companies shaping Europe’s future in innovation and global competitiveness. Our CEO, Celia Belline, will be on site to champion Cilcare’s vision and represent the company among Europe’s most forward-thinking leaders. 

The Enterprise Europe Network is the largest European initiative dedicated to helping SMEs innovate, grow, and expand globally. Through tailored advisory services, international matchmaking, and strategic mentoring, the Network supports thousands of companies each year in bringing their innovations to new markets.

Original article with accompanying video here.

Compliments of Cilcare – a member of the EACCNY